Spironolactone OGB 25 mg
Spironolactone is indicated in the management of:
- Primary hyperaldosteronism for diagnostic and treatment of primary hyperaldosteronism
- Edematous conditions for patients with congestive heart failure, cirrhosis of the liver accompanied by edema and/or ascites, and nephrotic syndrome
- Essential hypertension
Spironolactone 25 mg
10 strips of 10 tablets
This item should not be used with alcohol.
This item should not be used while operating heavy machinery.
This item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.
This item is not safe for use during lactation.
0 to 18 Years Old
Safety and effectiveness in pediatric patients have not been established.
18 Years Old and Above
Diagnosis and treatment of primary hyperaldosteronism
If it takes a long time to perform the test:
400 mg/day for 3-4 weeks.
If it takes a short time to perform the test:
400 mg/day for 4 days.
50-100 mg/day in single or divided doses.
Edema caused by cirrhosis of the liver with or without ascites:
Edema caused by nephrotic syndrome:
Usually 100-200 mg/day.
Initial dose 25 mg/day then increase to 100 mg/day in single or two divided doses. Dosage should be adjusted to blood pressure and potassium serum level.